Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma Multiforme Prior to and After Secondary Resection: an Open-Label Phase I/II Trial.
Phase of Trial: Phase I/II
Latest Information Update: 14 Sep 2011
At a glance
- Drugs Patupilone (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 28 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jan 2010 Planned number of patients changed from 24 to 10 as reported by ClinicalTrials.gov.
- 22 Jan 2010 Planned end date changed from 1 Dec 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.